 |
|
Imagining and Testing New Strategies for HIV/AIDS
A Call for Papers
Jeanette M. Smith, MD;
Richard M. Glass, MD
JAMA. 2003;290:2735.
Since an early report1 that presaged a global catastrophe, millions of deaths due to an incurable disease now known as AIDS have been reported.2-3 Even in a country with substantial resources to combat the disease, new cases continue to occur.4 However, awe-inspiring progress is evident in the development of powerful drugs5-6 that prolong life in individuals with human immunodeficiency virus (HIV) infection and in the number of programs in place to prevent additional infections and deaths.2-3,7-9 Such positive developments are tempered by the reality that huge gaps exist in access to effective therapies.3
In July 2004, THE JOURNAL will publish an entire issue on HIV/AIDS, with the date of publication to coincide with the 15th International AIDS Conference in Bangkok.10 We invite clinicians and researchers to bring their imagination, knowledge, and efforts to bear on issues of HIV prevention and treatment and to submit evidence-based reports for consideration for this theme issue.
Similar to the July 10, 2002, issue of JAMA devoted to HIV/AIDS, we welcome submission of papers on discoveries in HIV research and related basic medical science, and their application to medical practice. We are especially interested in receiving reports of original research, particularly randomized controlled trials that advance HIV treatment. We also look forward to receiving other scholarly articles, such as systematic reviews, special communications, and commentaries, that examine aspects of HIV-related research and clinical applications. Topics could include virological, immunological, or genetic basis of disease; environmental and behavioral factors and preventive interventions; epidemiology; therapy; and physician/patient education issues. Papers with a focus on issues of particular relevance to international settings would be of interest as well. Analyses of economic, ethical, and social policy implications of HIV-related research would also be welcome.
Submissions will be subject to rigorous editorial review, and if judged to be of potential interest, to evaluation by peer review with no advance guarantee of acceptance. High-quality submissions not selected for the theme issue may be considered for other issues of JAMA or for consideration by one of the Archives specialty journals.
We hope you are interested in making this effort a success by submitting an original manuscript for consideration for the issue. Please consult the JAMA Instructions for Authors11 when preparing and submitting the manuscript. Papers received by February 2, 2004, will have the best chance for consideration for the 2004 HIV/AIDS theme issue.
The progress gained in HIV disease has been remarkable, but many continue to suffer the cruel consequences of this disease. As we anticipate advances resulting from application of knowledge and imagination (and the necessary resources), we might remember that "Concern for man himself and his fate must always form the chief interest of all technical endeavors. . . . Never forget this in the midst of your diagrams and equations."12
AUTHOR INFORMATION
|
Corresponding Author: Jeanette M. Smith, MD, JAMA, 515 N State St, Chicago, IL 60610 (e-mail: jeanette_smith{at}jama-archives.org).
Editorials represent the opinions of the authors and THE JOURNAL and not those of the American Medical Association.
Author Affiliation: Dr Smith is Contributing Editor and Dr Glass is Deputy Editor, JAMA.
REFERENCES
|
1. US Centers for Disease Control and Prevention (CDC). Pneumocystis pneumonia–Los Angeles. MMWR Morb Mortal Wkly Rep. 1981;30:250-252.
PUBMED
2. Joint United Nations Programme on HIV/AIDS (UNAIDS). AIDS epidemic update: December 2002. Available at: http://www.unaids.org. Accessed October 30, 2003.
3. UNAIDS. Accelerating action against AIDS in Africa: executive summary. Available at: http://www.unaids.org/html/pub/UNA-docs/ICASA_Report_ExecutiveSummary_en_doc.htm. Accessed October 30, 2003.
4. CDC. Divisions of HIV/AIDS Prevention: basic statistics. Available at: http://www.cdc.gov/hiv/stats.htm. Accessed October 30, 2003.
5. Yeni PC, Hammer SM, Carpenter CCJ, et al. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA. 2002;288:222-235.
FREE FULL TEXT
6. National Institutes of Health AIDSinfo page. Overview of guidelines. Available at: http://www.aidsinfo.nih.gov/. Accessed October 30, 2003.
7. CDC National Prevention Information Network. Elements of successful HIV/AIDS prevention programs. Available at: http://www.cdcnpin.org/scripts/hiv/programs.asp. Accessed October 30, 2003.
8. National Institutes of Health, Division of AIDS home page. Available at: http://www.niaid.nih.gov/daids/. Accessed October 30, 2003.
9. World Health Organization. The risks of unsafe sex and AIDS: the World Health Organization's response. 2002. Available at: http://www.who.int/whr/media_centre/factsheet1/en. Accessed November 3, 2003.
10. 15th International AIDS Conference invitation page. International AIDS Society Web site. Available at: http://www.ias.se/aids2004/. Accessed October 30, 2003.
11. JAMA Instructions for Authors. JAMA. 2003;290:125-131. Also at: http://jama.ama-assn.org/ifora_current.dtl.
FREE FULL TEXT
12. Einstein A. Address before the student body, the California Institute of Technology, February 16, 1931. Tolman RC, trans. Located at: the Caltech Institute Archives, Pasadena, Calif.
|
